Outcome of Endometrial Cancer Stage IIIA with Adnexa or Serosal Involvement Only

被引:13
作者
Jobsen, Jan J. [1 ]
ten Cate, Lambert Naudin [2 ]
Lybeert, Marnix L. M. [3 ]
Scholten, Astrid [4 ]
van der Steen-Banasik, Elzbieta M. [5 ,6 ,7 ]
van der Palen, Job
Kroese, Marika C. Stenfert [8 ]
Slot, Annerie [9 ]
Schutter, Eltjo M. J. [10 ]
Siesling, Sabine [11 ]
机构
[1] Med Spectrum Twente, Dept Radiat Oncol, Haaksbergerstr 55, NL-7513 ER Enschede, Netherlands
[2] Lab Pathol Oost Nederland, NL-7512 ER Enschede, Netherlands
[3] Catharina Hosp, Dept Radiat Oncol, Eindhoven, Netherlands
[4] Leiden Univ, Med Ctr, Dept Clin Oncol, NL-2333 ZA Leiden, Netherlands
[5] Arnhem Radiotherapeut Inst, Arnhem, Netherlands
[6] Univ Twente, Fac Behav Sci, Dept Res Methodol Measurement & Data Anal, NL-7500 AE Enschede, Netherlands
[7] Med Spectrum Twente, Dept Clin Epidemiol, NL-7513 ER Enschede, Netherlands
[8] Radiotherapy Inst Steden Omstreken, Deventer, Netherlands
[9] Radiotherapy Inst Friesland, Leeuwarden, Netherlands
[10] Med Spectrum Twente, Dept Obstet & Gynaecol, NL-7513 ER Enschede, Netherlands
[11] Comprehens Canc Ctr North East, Enschede, Netherlands
关键词
D O I
10.1155/2011/962518
中图分类号
R71 [妇产科学];
学科分类号
100211 ;
摘要
Objective. The aim of this study is to look at possible differences in outcome between serosa and adnexal involvement stage IIIA endometrial carcinoma. Methods. 67 patients with stage IIIA endometrial carcinoma were included, 46 with adnexal involvement and 21 with serosa. A central histopathological review was performed. Results. The 7-year locoregional failure rate was (LRFR) 2.2% for adnexal involvement and 16.0% for involvement of the serosa (P =.0522). The 7-year distant metastasis-free survival was 72.7% for adnexal involvement and 58.7% for serosa (P =.3994). The 7-year disease-specific survival (DSS) was 71.8% for patients with adnexal involvement and 75.4% for patients with serosa. Conclusion. Endometrial carcinoma stage IIIA with involvement of the adnexa or serosa showed to have a comparable disease-specific survival. Locoregional control was worse for serosa involvement compared to adnexa.
引用
收藏
页数:7
相关论文
共 50 条
[41]   Is Molecular Classification by MMR Status Prognostic for Outcome in Stage IIIC Endometrial Cancer? [J].
Chipidza, F. E. ;
Yerramilli, D. ;
King, M. ;
Russo, A. L. ;
Lee, L. J. .
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2020, 108 (03) :E485-E486
[42]   Survival outcome of chemotherapy in stage IIIA and IIIB non-small cell lung cancer [J].
Aly, A. S. E. S. ;
Ellaithy, A. .
JOURNAL OF THORACIC ONCOLOGY, 2023, 18 (04) :S107-S107
[43]   SEROSAL INVASION AS THE SINGLE PROGNOSTIC INDICATOR IN STAGE-IIIA (T3N1M0) GASTRIC-CANCER [J].
ABE, S ;
SHIRAISHI, M ;
NAGAOKA, S ;
YOSHIMURA, H ;
DHAR, DK ;
NAKAMURA, T .
SURGERY, 1991, 109 (05) :582-588
[44]   Stage II endometrial cancer: Superficial cervical involvement is not an independent risk factor for recurrence [J].
Fader, A. Nickles ;
Skaznik-Wikiel, M. ;
Moxley, K. ;
Kunos, C. ;
Gibbons, H. ;
Resnick, K. E. ;
Moore, K. N. ;
Seamon, L. G. ;
Cohn, D. E. ;
Rose, P. G. .
GYNECOLOGIC ONCOLOGY, 2009, 112 (02) :S88-S88
[45]   Clinical and demographic factors in endometrial and ovary carcinoma: synchronous carcinoma vs stage IIIA endometrial carcinoma [J].
Baquedano Mainar, Laura ;
Navarro Sierra, Javier ;
Alvarez Sarrado, Leticia ;
Jose Gutierrez, Yasmina ;
Lamarca Ballestero, Marta ;
Rubio Cuesta, Patricia ;
Ruiz Pena, Ana C. ;
Espiau Romera, Andrea .
EUROPEAN JOURNAL OF GYNAECOLOGICAL ONCOLOGY, 2021, 42 (04) :643-648
[46]   CLINICAL OUTCOME IN ENDOMETRIAL CANCER [J].
KAUPPILA, A ;
GRONROOS, M ;
NIEMINEN, U .
OBSTETRICS AND GYNECOLOGY, 1982, 60 (04) :473-480
[47]   Multiple factor IIIA endometrial cancer is a marker of poor prognosis [J].
Lanneau, G. S. ;
Landrum, L. M. ;
Moore, K. N. ;
Smith, C. ;
Lanneau, M. S. ;
Frank, S. ;
Gold, M. A. ;
McMeekin, D. S. .
GYNECOLOGIC ONCOLOGY, 2007, 107 (02) :372-372
[48]   Involvement of chromosome 6 in endometrial cancer [J].
MG Tibiletti ;
B Bernasconi ;
M Taborelli ;
D Furlan ;
A Fabbri ;
M Franchi ;
R Taramelli ;
M Trubia ;
C Capella .
British Journal of Cancer, 1997, 75 :1831-1835
[49]   Outcome of combined-modality treatment for stage IIIA non-small-cell lung cancer [J].
ElSayed, S ;
Paprocki, I ;
Mihalciou, C ;
Chowdhury, A ;
Leylek, A ;
Unruh, H .
RADIOLOGY, 1996, 201 :1498-1498
[50]   Involvement of chromosome 6 in endometrial cancer [J].
Tibiletti, MG ;
Bernasconi, B ;
Taborelli, M ;
Furlan, D ;
Fabbri, A ;
Franchi, M ;
Taramelli, R ;
Trubia, M ;
Capella, C .
BRITISH JOURNAL OF CANCER, 1997, 75 (12) :1831-1835